Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,775 total articles

Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Zentalis Pharmaceuticals announced dosing of the first patient in its global Phase 3 ASPENOVA trial evaluating azenosertib, a first-in-class WEE1 inhibitor, against standard chemotherapy in Cyclin E1-positive platinum-resistant ovarian cancer patients. The trial supports a confirmatory study to complement the ongoing Phase 2 DENALI trial aiming for…

IZEA Announces Q1 2026 Earnings Results Conference Call

IZEA Announces Q1 2026 Earnings Results Conference Call

IZEA Worldwide, a leading influencer marketing company, announced its financial results conference call for first quarter 2026 will be held on May 12, 2026. The call will be hosted by the CEO and CFO and include a Q&A session. Investors are invited to attend via webcast or phone, with a replay available for a week. The company highlights its positi…

Core AI Appoints Sonali Garg, Former Meta Data Center Leader and COO of Allianca Group, to Advisory Board

Core AI Appoints Sonali Garg, Former Meta Data Center Leader and COO of Allianca Group, to Advisory Board

Core AI Holdings has appointed Sonali Garg, co-founder and COO of Allianca Group and former Meta data center leader, to its advisory board. This move enhances Core AI's execution capabilities as it advances its AI-ready data center platform in strategic partnership with Allianca, which specializes in rapid and scalable data center delivery. Garg br…

Enovix Corporation Appoints Steve Bakos as Senior Vice President of Worldwide Sales to Support Commercial Scale-up and Revenue Growth

Enovix Corporation Appoints Steve Bakos as Senior Vice President of Worldwide Sales to Support Commercial Scale-up and Revenue Growth

Enovix Corporation announced the appointment of Steve Bakos as Senior Vice President of Worldwide Sales to support the commercialization and scaling of its advanced silicon-anode lithium-ion batteries. This leadership addition comes at a pivotal time as Enovix aligns with a lead smartphone customer on a silicon-specific qualification framework, aim…

Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platform MITOLINE™

Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platform MITOLINE™

Nexentis Technologies Inc., through its wholly owned subsidiary MitoCareX Bio Ltd., announced the official U.S. trademark registration of its proprietary algorithm platform MITOLINE™, designed to advance mitochondrial drug discovery by enabling robust 3D modeling of mitochondrial carrier proteins. This milestone strengthens the company’s drug disco…

GD Culture Group Limited Announces Receipt of Preliminary Non-Binding Going Private Proposal at US$10.75 Per Share

GD Culture Group Limited Announces Receipt of Preliminary Non-Binding Going Private Proposal at US$10.75 Per Share

GD Culture Group Limited announced the receipt of a non-binding proposal from a consortium to acquire all outstanding shares not already owned by the consortium for $10.75 per share in cash, representing a premium of approximately 169% over recent trading prices. The Board plans to evaluate the offer and consider forming a special committee to nego…

WTW completes acquisition of Cushon, consolidating its position as 4th largest master trust provider in the U.K.

WTW completes acquisition of Cushon, consolidating its position as 4th largest master trust provider in the U.K.

Willis Towers Watson (WTW) has completed its acquisition of UK workplace pension and savings provider Cushon, following regulatory approval. This acquisition solidifies WTW's position as the fourth largest master trust provider in the UK defined contribution workplace pensions market, managing over £30 billion in assets for 1.2 million members. The…

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Cytokinetics announced that the pivotal Phase 3 ACACIA-HCM trial of aficamten met both of its primary endpoints, showing statistically significant improvements in symptoms and exercise capacity in patients with symptomatic non-obstructive hypertrophic cardiomyopathy (HCM). The drug demonstrated consistent benefits across key secondary measures with…

Telesat reports results for the quarter ended March 31, 2026

Telesat reports results for the quarter ended March 31, 2026

Telesat announced its Q1 2026 financial results showing a 25% revenue decline to CAD 87 million largely due to broadcast contract non-renewals in the GEO segment, while investing heavily (CAD 171 million) in its LEO Telesat Lightspeed constellation development targeted for commercial service launch around Q1 2028. The company reported a net loss of…

Kura Oncology to Report First Quarter 2026 Financial Results

Kura Oncology to Report First Quarter 2026 Financial Results

Kura Oncology, a biopharmaceutical company specializing in precision cancer medicines, will report its first quarter 2026 financial results on May 12, 2026. The company will host a webcast and conference call to discuss the results and provide a corporate update. Kura is known for KOMZIFTI, an FDA-approved oral menin inhibitor for certain leukemia …

Intellia Therapeutics to Participate in Upcoming Investor Conferences

Intellia Therapeutics to Participate in Upcoming Investor Conferences

Intellia Therapeutics, a clinical-stage biopharmaceutical company focused on CRISPR gene editing, will participate in investor fireside chats at three major healthcare conferences in May and June 2026. The events will be webcast live, offering investors insights into the company's mission to develop potentially curative treatments targeting the roo…

Cipher Digital Provides First Quarter 2026 Business Update

Cipher Digital Provides First Quarter 2026 Business Update

Cipher Digital reported significant progress in Q1 2026 with development milestones at its Barber Lake and Black Pearl data center campuses on schedule, signing a third AI data center lease with an investment-grade hyperscale tenant, and securing a $200 million revolving credit facility from leading global financial institutions to support ongoing …

ArcelorMittal announces results of its General Meetings

ArcelorMittal announces results of its General Meetings

At its General Meetings held on 5 May 2026, ArcelorMittal shareholders approved key corporate actions including a US$0.60 per share dividend distribution, re-election of current directors along with a new director, approval of share cancellation following buybacks, and renewal of board authorization to increase share capital. These approvals suppor…

Sow Good Secures $20 Million Non-Convertible Private Placement Credit Facility to Fund Critical Minerals Strategy

Sow Good Secures $20 Million Non-Convertible Private Placement Credit Facility to Fund Critical Minerals Strategy

Sow Good Inc. announced a $20 million non-convertible private placement credit facility with Sagol Advisors to fund its strategic acquisition of the Nachu Graphite Project in Tanzania. This funding supports Sow Good's transition into critical minerals and battery anode materials development, enhancing its position in the battery materials supply ch…

HII Reports First Quarter 2026 Results

HII Reports First Quarter 2026 Results

Huntington Ingalls Industries reported first quarter fiscal 2026 revenues of $3.1 billion, up 13.4% year-over-year, driven by growth across its shipbuilding and mission technology segments. Despite higher revenues, operating margins declined slightly, leading to net earnings and diluted EPS of $149 million and $3.79 respectively, unchanged from the…

Fiserv Reports First Quarter 2026 Results

Fiserv Reports First Quarter 2026 Results

Fiserv, Inc. reported first quarter 2026 GAAP revenue of $5.03 billion, down 2% year-over-year, with organic revenue down 4%. GAAP EPS declined 29%, and adjusted EPS fell 16%. The company confirmed 2026 organic revenue growth guidance of 1%-3% and adjusted EPS between $8.00 and $8.30. Operating margins declined notably compared to prior year period…